The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients
NCT ID: NCT01679366
Last Updated: 2014-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
57 participants
INTERVENTIONAL
2012-10-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
NCT00599430
Probiotics in Prevention of Common Cold
NCT02013934
The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children
NCT01935986
The Safety and Efficacy of Probiotic for Improving Intestinal and Immune Function
NCT06779994
The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children
NCT02640352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study design A prospective, randomized, placebo-controlled, double-blinded study comparing treatment with probiotics to placebo in patients with AP.
The study will be conducted in accordance with the ethical standards of the Helsinki Declaration and will be approved by the Human Experimentation Ethics Committee of the Ziv Medical Center. Signed informed consent will be required from all patients before inclusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Penicillin G
hospitalization of 30 patients given penicilline intraveniously for 72 hours
No interventions assigned to this group
Placebo
30 hospitalized patients will be given placebo with a regular penicillin treatment
Placebo
1 tablet 2 times daily
Probiotic
Probiotics will be given to 30 hospitalized patients with regular penicillin treatment
Probiotics
1 tablet twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
1 tablet 2 times daily
Probiotics
1 tablet twice daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute pharyngotonsillitis for which hospitalization for intravenous antibiotic treatment and/or fluids is needed
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziv Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonid Livshits, MD
Role: PRINCIPAL_INVESTIGATOR
Ziv Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziv Medical Center
Safed, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0054-11-ZIV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.